Literature DB >> 6434854

Glutaric aciduria type II: multiple defects in isolated muscle mitochondria and deficient beta-oxidation in fibroblasts.

P D Mooy, M A Giesberts, H H van Gelderen, H R Scholte, I E Luyt-Houwen, H Przyrembel, W Blom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6434854     DOI： 10.1007/978-94-009-5612-4_25

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

1.  Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells.

Authors:  H R Scholte; H F Busch; I E Luyt-Houwen; M H Vaandrager-Verduin; H Przyrembel; W F Arts
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Myopathy with abnormal mitochondria, transient low electron transport capacity in the respiratory chain, and absence of energy transduction at sites 1 and 2 in vitro.

Authors:  U Trockel; H R Scholte; K V Toyka; H F Busch; I E Luyt-Houwen; J A Berden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

3.  Difficulties in assessing biochemical properties of abnormal muscle mitochondria.

Authors:  H R Scholte; I E Luyt-Houwen; H F Busch
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

Review 4.  The inborn errors of mitochondrial fatty acid oxidation.

Authors:  C Vianey-Liaud; P Divry; N Gregersen; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 5.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

Review 6.  Riboflavin-responsive defects of beta-oxidation.

Authors:  N Gregersen
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

7.  Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin.

Authors:  P D Mooy; H Przyrembel; M A Giesberts; H R Scholte; W Blom; H H van Gelderen
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.